SCHEMBL4647935

SCHEMBL4647935

NC(=O)NN=C1C=C(Br)c2ccccc2C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 1/20 0.46
MAPT P10636 3/20 0.35
ALDH1A1 P00352 2/20 0.35
POLB P06746 2/20 0.35
NPC1 O15118 1/20 0.35
NSD2 O96028 1/20 0.35
RAB9A P51151 1/20 0.35
P2RX7 Q99572 1/20 0.34
LMNA P02545 1/20 0.34
KEAP1 Q14145 1/20 0.34
NFE2L2 Q16236 1/20 0.34
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
FGFR1 P11362 2/20 0.33
FGFR2 P21802 2/20 0.33
FGFR4 P22455 2/20 0.33
FGFR3 P22607 2/20 0.33
SRC P12931 1/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4647931 1.00 PTPRC (0.46) PTPRCMAPTALDH1A1POLBNPC1
SCHEMBL8175789 0.83 MEN1 (0.37) MAPTALDH1A1LMNAKEAP1NFE2L2
SCHEMBL4648990 0.82 IDO1 (0.43) MAPTALDH1A1LMNAKEAP1NFE2L2
SCHEMBL4648986 0.82 IDO1 (0.43) MAPTALDH1A1LMNAKEAP1NFE2L2
SCHEMBL4787268 0.79 PTPN1 (0.36) MAPTALDH1A1NPC1RAB9ALMNA
SCHEMBL4787270 0.79 PTPN1 (0.36) MAPTALDH1A1NPC1RAB9ALMNA
SCHEMBL8170720 0.75 CYP19A1 (0.37) PTPRCMAPTALDH1A1NSD2LMNA
SCHEMBL8173700 0.74 FGFR1 (0.36) PTPRCMAPTALDH1A1POLBNPC1
Naftazone SCHEMBL1697156 0.74 MEN1 (0.44) PTPRCMAPTALDH1A1POLBP2RX7
Naftazone SCHEMBL29615756 0.74 MEN1 (0.44) PTPRCMAPTALDH1A1POLBP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1961738-A1 New compounds with antiglutamatergic properties and uses thereof Faust Pharmaceuticals (FR) 2008-08-27 EP disclosed